A Randomized, Double-blind, Parallel-Group Study to Evaluate the Effects of First-Line Treatment With a Free Combination of Nebivolol and Lisinopril Compared With Placebo and the Monotherapy Components on Blood Pressure in Patients With Stage 2 Diastolic Hypertension.

Trial Profile

A Randomized, Double-blind, Parallel-Group Study to Evaluate the Effects of First-Line Treatment With a Free Combination of Nebivolol and Lisinopril Compared With Placebo and the Monotherapy Components on Blood Pressure in Patients With Stage 2 Diastolic Hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2012

At a glance

  • Drugs Lisinopril (Primary) ; Nebivolol (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 01 Sep 2012 Results published in the Journal of Clinical Hypertension (Greenwich).
    • 27 Jul 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
    • 27 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top